News

This guide to lateral flow assay development explains how to improve assay sensitivity and reproducibility through antibody screening, membrane selection, conjugate optimisation, strip design and process control.

Moya joins us at an exciting stage for our Lateral Flow Development services. Moya brings over 15 years’ experience in Lateral Flow Assay development  and a reputation for excellence in the field, with technical lab expertise, project management skills, and proven leadership. She has a strong track record of taking assays from development through to manufacturing, across multiple sectors, assay types and deployment settings. In her new role she will lead projects from feasibi

We are excited to announce that Fleet Bioprocessing Ltd . are launching a new service: from today we will be offering contract development of lateral flow devices (LFDs) to our customers. LFDs form a cornerstone of modern diagnostics, providing a rapid means to detect diseases in a point-of-care (POC) format that can be used in people’s own homes or in primary care, with broader applications spanning clinical, veterinary, industrial and environmental settings. Traditionally